30 Miss. Code. R. 2901-12.8 - Mississippi Prescription Monitoring Program (MPMP) and Urine Drug Screening

A. Certifying Practitioners who certify patients for cannabis must review the MPMP at each patient encounter involving certification, re-certification, or follow-up related to medical cannabis.

1) MPMP data reviewed shall include all information since the previous review.

2) The certifying practitioner shall note in the patient's chart that the MPMP was reviewed and provide appropriate information regarding the findings of said review.

B. Urine Drug Screening (UDS) and Other Diagnostic Tests.

1) As part of the in-person evaluation of a patient for initial certification or for re-certification each year, certifying practitioners shall conduct urine drug screening (UDS) and other diagnostic tests necessary for full evaluation of the patient's eligibility for medical cannabis.

2) In the absence of urine, other testing methods may be used.

3) Tests must include, at a minimum, assays for opioids, benzodiazepines, amphetamines, cocaine, and cannabis. Inconsistent UDS should be utilized as a tool to determine compliance with treatment.

Notes

30 Miss. Code. R. 2901-12.8

Miss. Code Ann. § 73-19-9 (1972, as Adopted).

Adopted 11/21/2022